[ Price : $8.95]
Four stakeholders suggest changes to a CDRH/CBER draft guidance on incorporating patient preference information over the total pro...[ Price : $8.95]
scPharmaceuticals says a planned supplemental NDA submission of an autoinjector as an alternative to the current on-body infusor u...[ Price : $8.95]
Federal Register notice: FDA announces the renewal of its Science Board for an additional two years.[ Price : $8.95]
Troutman Pepper attorneys explain the potential benefits in FDAs new Emerging Drug Safety Technology Program.[ Price : $8.95]
FDA plans to ask its Vaccines and Related Biological Products Advisory Committee to discuss potential safety concerns related to p...[ Price : $8.95]
The National Institutes of Health ends a trial of an mpox antiviral drug that failed to produce an efficacy signal.[ Price : $8.95]
Federal Register notice: FDA announces the revocation of B. Braun Medical emergency use authorizations for three Covid-related dev...